Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Jennifer W. Leiding, Danielle E. Arnold, Suhag Parikh, Brent Logan, Rebecca A. Marsh, Linda M. Griffith, Ruizhe Wu, Sharon Kidd, Kanwaldeep Mallhi, Deepak Chellapandian, Stephanie J. Si Lim, Eyal Grunebaum, E. Liana Falcone, Luis Murguia-Favela, Debbi Grossman, Vinod K. Prasad, Jennifer R. Heimall, Fabien Touzot, Lauri M. Burroughs, Jack Bleesing, Neena Kapoor, Jasmeen Dara, Olatundun Williams, Malika Kapadia, Benjamin R. Oshrine, Jeffrey J. Bednarski, Ahmad Rayes, Hey Chong, Geoffrey D. E. Cuvelier, Lisa R. Forbes Satter, Caridad Martinez, Mark T. Vander Lugt, Lolie C. Yu, Shanmuganathan Chandrakasan, Avni Joshi, Susan E. Prockop, Blachy J. Dávila Saldaña, Victor Aquino, Larisa A. Broglie, Christen L. Ebens, Lisa M. Madden, Kenneth DeSantes, Jordan Milner, Hemalatha G. Rangarajan, Ami J. Shah, Alfred P. Gillio, Alan P. Knutsen, Holly K. Miller, Theodore B. Moore, Pamela Graham, Andrea Bauchat, Nancy J. Bunin, Pierre Teira, Aleksandra Petrovic, Sharat Chandra, Hisham Abdel-Azim, Morna J. Dorsey, Olga Birbrayer, Morton J. Cowan, Christopher C. Dvorak, Elie Haddad, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer M. Puck, Michael A. Pulsipher, Troy R. Torgerson, Harry L. Malech, Elizabeth M. Kang

Blood (2023) 142 (24): 2105–2118.

https://doi.org/10.1182/blood.2022019586

Published: 2023

Includes: Supplemental data

Journal Articles

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

Elie Haddad, Brent R. Logan, Linda M. Griffith, Rebecca H. Buckley, Roberta E. Parrott, Susan E. Prockop, Trudy N. Small, Jessica Chaisson, Christopher C. Dvorak, Megan Murnane, Neena Kapoor, Hisham Abdel-Azim, Imelda C. Hanson, Caridad Martinez, Jack J. H. Bleesing, Sharat Chandra, Angela R. Smith, Matthew E. Cavanaugh, Soma Jyonouchi, Kathleen E. Sullivan, Lauri Burroughs, Suzanne Skoda-Smith, Ann E. Haight, Audrey G. Tumlin, Troy C. Quigg, Candace Taylor, Blachy J. Dávila Saldaña, Michael D. Keller, Christine M. Seroogy, Kenneth B. Desantes, Aleksandra Petrovic, Jennifer W. Leiding, David C. Shyr, Hélène Decaluwe, Pierre Teira, Alfred P. Gillio, Alan P. Knutsen, Theodore B. Moore, Morris Kletzel, John A. Craddock, Victor Aquino, Jeffrey H. Davis, Lolie C. Yu, Geoffrey D. E. Cuvelier, Jeffrey J. Bednarski, Frederick D. Goldman, Elizabeth M. Kang, Evan Shereck, Matthew H. Porteus, James A. Connelly, Thomas A. Fleisher, Harry L. Malech, William T. Shearer, Paul Szabolcs, Monica S. Thakar, Mark T. Vander Lugt, Jennifer Heimall, Ziyan Yin, Michael A. Pulsipher, Sung-Yun Pai, Donald B. Kohn, Jennifer M. Puck, Morton J. Cowan, Richard J. O'Reilly, Luigi D. Notarangelo

Blood (2018) 132 (17): 1737–1749.

https://doi.org/10.1182/blood-2018-03-840702

Published: 2018

Includes: Supplemental data

Journal Articles

The Contribution of the Thymus to Autoimmune Phenotypes in GvHD and Colitis

Karlie R. Sharma, PhD, Sarah E Bryant, BS, Sherry Koontz, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2016) 128 (22): 3347.

https://doi.org/10.1182/blood.V128.22.3347.3347

Published: 2016

Journal Articles

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

Elizabeth M. Kang, MD, Nicola A. Wright, MD FRCPC, Katherine Nicholls, MBBS, FRACP, FRCPA, Dianne Hilligoss, RN, MSN, CRNP, Corin Kelly, RN, Douglas B. Kuhns, PhD, Harry L. Malech, MD

Blood (2015) 126 (23): 5515.

https://doi.org/10.1182/blood.V126.23.5515.5515

Published: 2015

Journal Articles

Graft Versus Host Disease (GvHD) Is Attenuated By Administration of Pregnancy Specific Glycoproteins through Induction of Immune Tolerance

Karlie R. Sharma, PhD, Shemona Rattila, Patricia Kiesler, PhD, Angela Ballesteros, PhD, Jian Luo, PhD, Sherry Koontz, James Warren, MS, Harry L. Malech, MD, Gabriela Dveksler, PhD, Elizabeth M. Kang, MD

Blood (2015) 126 (23): 4278.

https://doi.org/10.1182/blood.V126.23.4278.4278

Published: 2015

Journal Articles

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

Sabrina Martyr, MD, Arun Balakumuran, MD, PhD, Aldemar Montero, MD, Cynthia E. Dunbar, MD, Elizabeth M. Kang, MD, Phillip Scheinberg, MD, Barbara Weinstein, RN, Xin Tian, Ph.D., Neal S. Young, MD, Adrian Wiestner, MD, PhD

Blood (2013) 122 (21): 2479.

https://doi.org/10.1182/blood.V122.21.2479.2479

Published: 2013

Journal Articles

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Elizabeth M. Kang, MD, Harry Malech, MD, Dianne Hilligoss, Martha Marquesen, Corin Kelly, Mark Parta, MD

Blood (2013) 122 (21): 2157.

https://doi.org/10.1182/blood.V122.21.2157.2157

Published: 2013

Journal Articles

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

P. Dayand Borge, Jr., MD, Narda Theobald, MA, Rosamma DeCastro, NP, Harry L. Malech, MD, Susan Leitman, MD, Elizabeth M. Kang, MD

Blood (2010) 116 (21): 1329.

https://doi.org/10.1182/blood.V116.21.1329.1329

Published: 2010

Journal Articles

Adenosine A 2A Receptor Agonist Mediated Prevention of Graft-Versus Host Disease In the Mouse Is Associated with An Increase of T-Regulatory Cells In Target Organs.

Kyu Lee Han, PhD, Sherry Walker, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2010) 116 (21): 3744.

https://doi.org/10.1182/blood.V116.21.3744.3744

Published: 2010

Journal Articles

Hypomorphic Rag mutations can cause destructive midline granulomatous disease

Suk See De Ravin, Edward W. Cowen, Kol A. Zarember, Narda L. Whiting-Theobald, Douglas B. Kuhns, Netanya G. Sandler, Daniel C. Douek, Stefania Pittaluga, Pietro L. Poliani, Yu Nee Lee, Luigi D. Notarangelo, Lei Wang, Frederick W. Alt, Elizabeth M. Kang, Joshua D. Milner, Julie E. Niemela, Mary Fontana-Penn, Sara H. Sinal, Harry L. Malech

Blood (2010) 116 (8): 1263–1271.

https://doi.org/10.1182/blood-2010-02-267583

Published: 2010

Journal Articles

Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils

Elizabeth M. Kang, Uimook Choi, Narda Theobald, Gilda Linton, Debra A. Long Priel, Doug Kuhns, Harry L. Malech

Blood (2010) 115 (4): 783–791.

https://doi.org/10.1182/blood-2009-05-222760

Published: 2010

Includes: Supplemental data

Journal Articles

Activation of the Adenosine A 2A Receptor Promotes the Development of Donor-Derived T Regulatory Cells in a Graft-Versus Host Disease Mouse Model.

Kyu Lee Han, PhD, Cattlena M. Changpriroa, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2009) 114 (22): 1339.

https://doi.org/10.1182/blood.V114.22.1339.1339

Published: 2009

Journal Articles

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population

Sumithira Vasu, Susan F. Leitman, John F. Tisdale, Matthew M. Hsieh, Richard W. Childs, A. John Barrett, Daniel H. Fowler, Michael R. Bishop, Elizabeth M. Kang, Harry L. Malech, Cynthia E. Dunbar, Hanh M. Khuu, Robert Wesley, Yu Y. Yau, Charles D. Bolan

Blood (2008) 112 (5): 2092–2100.

https://doi.org/10.1182/blood-2008-03-143677

Published: 2008

Journal Articles

Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.

Elizabeth M. Kang, MD, Gilda Linton, Narda Theobald, Sandra Anaya O’Brien, RN, Dianne Hilligoss, CNP, Harry L. Malech, MD

Blood (2007) 110 (11): 504.

https://doi.org/10.1182/blood.V110.11.504.504

Published: 2007

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Matthew M. Hsieh, MD, Elizabeth M. Kang, MD, Beth Link, Maria Berg, Richard W. Childs, MD, Roger Kurlander, MD, Jonathan Powell, MD PhD, Griffin P. Rodgers, MD, John F. Tisdale, MD

Blood (2006) 108 (11): 2994.

https://doi.org/10.1182/blood.V108.11.2994.2994

Published: 2006

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Elizabeth M. Kang, MD, Matthew Hsieh, MD, Jonathan D. Powell, MD/PhD, Beth Link, RN, Theresa Donohue, PA, Gregory Kato, MD, Robert Machado, MD, Mark Gladwin, MD, Griffin Rodgers, MD, John F. Tisdale, MD

Blood (2005) 106 (11): 5429.

https://doi.org/10.1182/blood.V106.11.5429.5429

Published: 2005

Journal Articles

Cloning and Functional Analysis of the Rhesus Macaque ABCG2 Gene: Forced Expression Confers an SP Phenotype among Hematopoietic Stem Cell Progeny in Vivo.

Takahiro Ueda, M.D., Sebastian Brenner, M.D., Harry Malech, M.D., Saskia Langemeijer, Martha Kirby, Oswald Phang, Allen Krouse, Robert E. Donahue, D.V.M., Elizabeth M. Kang, M.D., John F. Tisdale, M.D.

Blood (2004) 104 (11): 3219.

https://doi.org/10.1182/blood.V104.11.3219.3219

Published: 2004

Journal Articles

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait

Elizabeth M. Kang, Ellen M. Areman, Virginia David-Ocampo, Courtney Fitzhugh, Mary E. Link, Elizabeth J. Read, Susan F. Leitman, Griffin P. Rodgers, John F. Tisdale

Blood (2002) 99 (3): 850–855.

https://doi.org/10.1182/blood.V99.3.850

Published: 2002

Journal Articles

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome

Elizabeth M. Kang, Moniek de Witte, Harry Malech, Richard A. Morgan, Sheila Phang, Charles Carter, Susan F. Leitman, Richard Childs, A. John Barrett, Richard Little, John F. Tisdale

Blood (2002) 99 (2): 698–701.

https://doi.org/10.1182/blood.V99.2.698

Published: 2002

NARROW

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

The Contribution of the Thymus to Autoimmune Phenotypes in GvHD and Colitis

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

Graft Versus Host Disease (GvHD) Is Attenuated By Administration of Pregnancy Specific Glycoproteins through Induction of Immune Tolerance

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

Adenosine A 2A Receptor Agonist Mediated Prevention of Graft-Versus Host Disease In the Mouse Is Associated with An Increase of T-Regulatory Cells In Target Organs.

Hypomorphic Rag mutations can cause destructive midline granulomatous disease

Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils

Activation of the Adenosine A 2A Receptor Promotes the Development of Donor-Derived T Regulatory Cells in a Graft-Versus Host Disease Mouse Model.

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population

Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Cloning and Functional Analysis of the Rhesus Macaque ABCG2 Gene: Forced Expression Confers an SP Phenotype among Hematopoietic Stem Cell Progeny in Vivo.

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only